5th versus the 1st quintile. Using the IDF criteria, an inverse association between fiber intake and the MS was obtained whereas a direct association was found between carbohydrate intake and the MS: OR = 1.71 (95% CI: 1.05-2.79) for the highest versus the lowest quintile. Conclusions: A diet rich in fiber and PUFAs is correlated with a reduced risk of MS in subjects at high cardiovascular risk.
dietary composition has been less well studied. In particular, there are conflicting results regarding the influence of macronutrient intake on the MS [5, 7] . In a large crosssectional study of British civil servants, a higher intake of carbohydrate and polyunsaturated fatty acids (PUFAs) was linked to benefits with regard to central obesity, fasting triglycerides and LDL cholesterol while a higher carbohydrate intake was linked with lower HDL cholesterol, increased postprandial glucose and insulin levels in normoglycemic subjects [8] . Another cross-sectional study evaluated the association between macronutrient intake and the prevalence of the MS in a sample of 1,626 subjects (mean age 52 years) with at least one cardiovascular risk factor, and reported an inverse relationship between carbohydrate intake and the prevalence of the MS [9] .
Taking into account these contradictory results, the aim of our study was to evaluate the role of macronutrients, including fiber and fatty acids, in the occurrence of MS features in a sample of subjects at high cardiovascular risk.
Subjects and Methods
A cross-sectional study was carried out on 967 subjects (434 men and 533 women, mean age 67.6 years) who were attending seven primary health care centers in Pamplona (Northern Spain). All the subjects were considered to be at high cardiovascular risk and were community-dwelling. The selection took place between March 2004 and April 2005 using the computerized clinical records of these patients. The inclusion criteria comprised type 2 DM or 3 or more cardiovascular risk factors: current smoking, blood pressure 6 140/90 mm Hg or treatment with antihypertensive drugs, high LDL cholesterol ( 6 160 mg/dl) or low HDL cholesterol ( ! 40 mg/dl) levels or treatment with lipid-lowering drugs and/or a body mass index (BMI) 6 25 (kg/m 2 ). The exclusion criteria included a previous history of CVD, severe chronic illness, and drug or alcohol addiction. All preselected subjects were contacted by their physicians, who informed them about the nature and the purpose of the study ( fig. 1 ) ; 54.9% of the contacted patients agreed to participate in the study and gave their written consent. The protocol was approved by the ethics committee of the Clínica Universidad de Navarra.
The MS diagnosis was based on the criteria of the National Cholesterol Education Program Adult Treatment Panel III (ATP3) and the criteria of the International Diabetes Federation (IDF). The ATP3 definition includes: waist circumference (men 1 102 cm women 1 88 cm), triglycerides 6 150 mg/dl, low HDL cholesterol ( ! 40 mg/dl men; ! 50 mg/dl women), blood pressure 6 130/ 6 85 mm Hg, fasting glucose 6 110 mg/dl. A diagnosis of MS was established when 3 or more of those risk determinants were present [10] . The IDF criteria include: abdominal obesity (waist circumference 6 94 cm for men and 6 80 cm for women, or a BMI 6 30) and 2 or more of the following: triglycerides 6 150 mg/dl; HDL cholesterol ! 40 mg/dl in men; ! 50 mg/dl in women; blood pressure 6 130 mm Hg/ 6 85 mm Hg, fasting glucose 6 100 mg/dl. Subjects receiving pharmacological treatment for high blood pressure, hypertriglyceridemia, low HDL cholesterol or diabetes were considered as positive for those criteria [1] .
Dietary Assessment
Food intake was assessed by a trained dietician using a 137-item semiquantitative food frequency questionnaire previously validated in Spain [11] . The nutrient intake was calculated as the frequency of consumption multiplied by the nutrient composition of the specified portion size. Nutrient composition was estimated using Spanish food composition tables [12, 13] .
Measurements
Weight and height were measured using calibrated scales and a wall-mounted stadiometer, respectively; waist circumference was measured at the midline between the last rib and the iliac crest. Blood pressure (average of 3 measurements) was recorded using a validated semiautomatic oscillometer (Omron HEM-705CP; Omron, Hoofddorp, The Netherlands). A fasting venous blood sample was drawn by a trained nurse. Plasma glucose was determined by the glucose-oxidase method; cholesterol and triglyceride levels were assayed by enzymatic procedures; HDL cholesterol level was measured after precipitation with phosphotungstic acid and magnesium chloride by routine procedures. 
Covariates
Smoking status was categorized into never, current or past smoking. Educational status was categorized into illiterate, primary, secondary or higher. Physical activity was assessed using the validated Spanish version of the Minnesota questionnaire [14, 15] . Energy expenditure was derived from the information gathered on 67 different activities and their energy expenditure and was expressed in kilocalories/day.
Statistical Analysis
Nutrient intakes (grams/day) were examined as individual variables, adjusted for total energy intake. Energy-adjusted nutrient intakes were calculated as the residuals from regression models with total intake of each nutrient as the dependent variable and total caloric intake as the independent variable [16] .
We ran several logistic regression models using the MS as the outcome, and 4 dummy variables corresponding to the 4 upper quintiles of intake of each nutrient as independent variables (the lowest quintile was the reference category).
Adjustments were made for potential confounders: age, sex, total energy intake, DM, smoking, alcohol intake (grams/day), educational level, marital status and physical activity. However, no adjustments were carried out for BMI or waist circumference because BMI is not a reliable measure of obesity in the elderly, due to changes in height with age and to the different ratio of lean to fat mass compared to younger adults [17] . Furthermore, since waist circumference is included in the definition of the outcome, adjusting for it was considered to be unnecessary.
We calculated the 'p for linear trend,' taking the median of each quintile of intake; this new variable was modeled as a continuous variable. All p values were two tailed and p ! 0.05 was considered to be statistically significant. The statistical analyses were performed using SPSS version 15.0 (SPSS Inc., Chicago, Ill., USA).
Results
The clinical, laboratory and nutrient intake characteristics of the participants are shown in table 1 , according to the presence of the MS for each definition. 55.1% were female; the mean age of the group was 67.6 8 6.2 years (mean 8 SD). As expected, subjects with the MS showed higher values for: waist circumference, weight, BMI, triglyceride levels, fasting plasma glucose and blood pressure. Unexpectedly, physical activity was higher in those with the MS although this difference was not statistically significant. Furthermore, the percentage of former smokers and the percentage of DM were also higher in the MS group ( table 1 ) . Statistically significant differences were observed between subjects with and without the MS for: total energy intake, simple sugar intake, dietary glycemic load and percentage of dietary protein using either the ATP3 or the IDF criteria. Differences in PUFA and fiber intake were seen for subjects with the MS using the ATP3 criteria.
Applying the ATP3 criteria, MS prevalence was found to be 42.4% for men and 47.5% for women. Based on the IDF definition, MS prevalence was 63.6%, there being no difference between men and women. The most prevalent components of the MS were hypertension, central obesity and elevated fasting glucose for both definitions. These findings are shown in table 2 .
According to the ATP3 criteria and after adjusting for confounding factors, we found a lower risk of developing the MS in the highest quintile of fiber intake with OR = 0.55 (95% CI: 0.35-0.86) with respect to the lowest quintile (p for linear trend = 0.016) ( table 3 ). The highest quintile of PUFA intake was inversely associated with MS prevalence with an adjusted OR = 0.60 (95% CI: 0.39-0.94; p for linear trend = 0.012) ( table 4 ). An analysis of the different ratios of fat showed that only the monounsaturated fatty acid/polyunsaturated fatty acid ratio (MUFA/ PUFA) was directly associated with the MS, with an adjusted OR of 1.99 (95% CI: 1.28-3.07) for the 5th versus the 1st quintile (p for linear trend = 0.006; data not shown).
When the MS was defined according to IDF criteria, the adjusted OR for carbohydrate intake was 1.71 (95% CI: 1.05-2.79) for the highest versus the lowest quintile of intake (p for linear trend = 0.038) whereas total fat intake was associated with a lower risk of MS; however, the association was not statistically significant (OR = 0.65, 95% CI: 0.04-1.02). Dietary fiber maintained an inverse association with an adjusted OR of 0.60 (95% CI: 0.38-0.95) for the 5th versus the 1st quintile, p for linear trend = 0.012 ( table 3 ) . We have not found any statistically significant relationship between fatty acids and the MS ( table 4 ) or the different ratios of fat and the MS according to IDF criteria.
When we analyzed simple sugars, polysaccharides, glycemic load or glycemic index, a higher risk of MS was associated only with polysaccharide intake (OR = 1.56, 95% CI: 1.00-2.45; p for linear trend 0.038) for the highest versus the lowest quintile of intake (data not shown).
Discussion
There is no consensus on the etiology and diagnostic criteria of the MS. Many studies compared the IDF and ATP3 criteria. In this study, we have used both criteria in order to expand the scope of our findings.
According to the ATP3 definition, the prevalence of the MS was 45.2% and was slightly higher in women than in men. With the IDF criteria we found that the prevalence of the MS was 63.4%, there being no difference between The continuous variables are represented as means 8 SD and the categorical variables are represented by the number of subjects (percentages shown in parentheses). ACE inhibitors = Angiotensin converting enzyme inhibitors; MUFAs = monounsaturated fatty acids; PUFAs = polyunsaturated fatty acids; SFAs = saturated fatty acids. 1 Body mass index was calculated dividing weight by squared height (kg/m 2 ). 2 All dietary variables were adjusted for total energy intake by using the residual method. 3 Dietary glycemic load is the amount of carbohydrate in a serving of food multiplied by that food's glycemic index (Using glucose as a reference). 4 Dietary glycemic index is defined as glycemic load divided by the total amount of carbohydrates. men and women. The prevalence according to IDF criteria was higher than reported in previous studies with similar demographic characteristics [18] . In a sample of 2,649 patients (mean age 64 years) with hypertension, DM or dyslipidemia, the Control of Cardiovascular Risk Factors in Primary Care in Spain (PREVENCAT study) reported a 50.6% prevalence of the MS based on the IDF criteria [18] . The prevalence of the MS in the general Spanish population is uncertain. Small studies in the Canary Islands and Segovia have reported prevalence estimates between 24.4 and 17%, respectively [19, 20] . A recently published study with a random sample (n = 1,433) of the adult population of Madrid (mean age 53 years) found a prevalence of 24.6 and 30.9% based on the ATP3 and IDF definitions, respectively [21] . Furthermore, a study on the general population of Navarra found MS prevalence rates of 22.1% for men and 17.2% for women based on the ATP3 criteria [22] .
High blood pressure and obesity were the most common conditions in our sample independently of the diagnostic criteria used; these findings are in agreement with previous studies of cardiovascular risk factors in Spain [18, 23] .
The differences in the prevalence of the MS as a function of the criteria applied (ATP3 or IDF) can be explained by the lower thresholds used by the IDF compared to the ATP3 for both abdominal obesity and fasting glucose [1] , resulting in more subjects being considered as suffering from the MS and a lower percentage of diabetic patients being included in the MS group.
Previous studies have also reported a detrimental role of carbohydrate intake. The Third National Health and Nutrition Examination Survey (NHANES III survey), for instance, which used ATP3 criteria, reported that a lower and moderate consumption of carbohydrates was associated with a lower prevalence of the MS only in men [24] . In this study, the authors found that a high carbohydrate intake is associated with lower HDL cholesterol and higher triglyceride concentrations. Knopp et al. [25] made similar observations in an interventional study with diets containing various quantities of carbohydrates and fat; subjects with higher carbohydrate intakes exhibited a 39% increase in their triglyceride levels. However, a recent study based on a model of substitution of nutrients reported contrasting data, i.e. subjects with higher carbohydrate and lower fat intakes exhibited a lower risk of developing the MS [9] . Nevertheless, methodological issues may be responsible for these findings: total energy intake was lower than expected for this population and there was no adjustment for dietary fiber intake. In the OMNIHEART study, replacement of carbohydrates by proteins or MUFAs led to further improvements in cardiovascular risk factors [26] .
We only observed a significant inverse association between PUFA intake and the prevalence of the MS when using the ATP3 criteria. Previous studies found that dietary n-3 PUFAs may contribute to a reduction in insulin resistance in muscles, an improved plasma lipoprotein profile, decreased triacylglycerol concentrations and in- 2 Triglycerides ≥150 mg/dl (IDF and ATP3 criteria). 3 HDL cholesterol <40 mg/dl in men, <50 mg/dl in women (IDF and ATP3 criteria). 4 Systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥85 mm Hg or pharmacological treatment for high blood pressure (IDF criteria). Systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg (ATP3 criteria). 5 Plasma glucose ≥100 mg/dl or pharmacological treatment for diabetes (IDF criteria). Plasma glucose ≥110 mg/dl (ATP3 criteria).
creased anti-inflammatory and antithrombotic responses [27, 28] . There is also evidence that PUFAs could reduce plasma glucose and thereby improve insulin sensitivity [29] .
It should also be mentioned that a higher intake of PUFAs instead of saturated fatty acids may improve blood pressure control, endothelial dysfunction, coagulation factors and insulin resistance and could also reduce the risk of developing MS [30] .
A review of the effects of dietary MUFAs suggests that a MUFA-enriched diet reduces the need for insulin, decreases glycemia in diabetics and could also lower blood pressure [27] . Insulin secretion is directly related to MUFA intake, independently of the level of insulin resistance [31] . Indeed, there is also laboratory and epidemiological evidence to suggest that MUFAs, and particularly olive oil, could exert beneficial effects in the prevention of hypertension [32] . We found no relationship between MUFA intake and the risk of MS in our study. However, a larger MUFA/PUFA ratio increased the risk of MS. These observations could be explained by the different sources of MUFAs consumed by our participants. The main source of MUFAs was olive oil although MUFAs from meat were important as well: on average 23% of the MUFA intake in our sample came from meat or meat products. Therefore, the beneficial effects that could be ascribed to MUFA consumption may be offset by the increased meat consumption. In this sense, the type of fat, rather than total fat intake is an emerging determinant associated with the development of the MS [30] . In our study, fiber intake was associated with a lower risk of MS. Available evidence supports the notion that diets supplemented with fiber may improve lipid profiles, glucose tolerance and intestinal function [33] . Dietary fiber exerts clinical benefits on all features of the MS. A fiber-rich diet reduces body weight gain [34] , dyslipidemia and blood pressure and improves insulin sensitivity [35] . A pooled analysis from several large cohort studies has shown that dietary fiber from fruits and cereals is inversely associated with the risk of coronary disease [36] .
The mechanisms involved in the beneficial effect of fiber intake remain largely unexplained. It has been proposed that it accounts for a reduction in glucose absorption as it induces a reduction in the inflammatory mediators associated with hyperglycemia. It has also been suggested that dietary fiber could reduce oxidative stress and the release of inflammatory mediators when analyzed as a component of the Mediterranean diet [37] [38] [39] [40] [41] [42] . A study of the Framingham Offspring cohort found that the fiber from cereals was inversely related with the prevalence of the MS even after adjustment for a wide array of confounding factors [40] . Considering the types (soluble and insoluble) and the numerous sources of dietary fibers, it is difficult to identify the predominant mechanisms in the beneficial effects exerted by dietary fiber on the MS. Both types of fiber are beneficial and probably complementary in reducing the risk of CVD and DM [35] . Another limitation of the studies on fiber intake is the difficulty in separating the effects of fiber and those derived from trace elements such as magnesium or from other dietary components, such as PUFAs, which are highly correlated with fiber intake [43, 44] . This limitation may also be present in our analysis.
Our study has some limitations because of its crosssectional design, as this precludes establishing a cause-effect relationship (because an inverse causality bias cannot be ruled out). The sample is not representative of the general population because it was selected on the basis of the existence of various cardiovascular risk factors. This selection procedure reduces between-subject variability more than what would be expected in a general population sample. Our results may not be applicable to the general population, but they can be used to describe the effect of macronutrient intake on the prevalence of the MS among subjects with a high cardiovascular risk. Furthermore, our data on food intake were obtained using food frequency questionnaires which have well-known limitations although they are most frequently used in nutritional epidemiology [16] . In our study, a trained dietician conducted the interviews to collect the food frequency data; it is hoped that this approach (as compared with self-administration) reduced any potential misclassification bias. In spite of multivariate adjustments, we cannot totally exclude the possibility of residual confounding.
The association between macronutrient intake and the MS varies depending on the diagnostic criteria applied, probably because some of the cut-off points are different in each definition. In this respect, the proportion of diabetics included is higher when the ATP3 criteria are used. It should also be borne in mind that diabetics are following dietary recommendations that may confound the interpretation of the role of macronutrient intake in the MS. The IDF criteria are less susceptible to this bias, thus enabling a better evaluation of the impact of nutrient intake on the MS risk.
As the MS is a major cardiovascular and diabetes risk factor, well-designed dietary recommendations are needed to reduce its prevalence in the population. Our results suggest a diet with high fiber and PUFA intakes as a potential strategy for the prevention of this disorder among high-risk subjects. Larger prospective studies with better controlled diets should be carried out to establish further nutritional recommendations to reduce the risk of MS.
